Compare LCII & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCII | ADPT |
|---|---|---|
| Founded | 1956 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.5B |
| IPO Year | N/A | 2019 |
| Metric | LCII | ADPT |
|---|---|---|
| Price | $126.76 | $16.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $102.40 | $16.60 |
| AVG Volume (30 Days) | 230.4K | ★ 2.5M |
| Earning Date | 02-10-2026 | 02-10-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | ★ 38.80 | N/A |
| EPS | ★ 7.12 | N/A |
| Revenue | ★ $3,992,455,000.00 | $252,754,000.00 |
| Revenue This Year | $10.93 | $50.81 |
| Revenue Next Year | $4.29 | $1.17 |
| P/E Ratio | $17.75 | ★ N/A |
| Revenue Growth | 5.74 | ★ 42.57 |
| 52 Week Low | $72.31 | $5.98 |
| 52 Week High | $126.56 | $20.76 |
| Indicator | LCII | ADPT |
|---|---|---|
| Relative Strength Index (RSI) | 73.52 | 52.58 |
| Support Level | $122.53 | $15.31 |
| Resistance Level | $125.00 | $16.82 |
| Average True Range (ATR) | 2.45 | 0.72 |
| MACD | -0.24 | -0.02 |
| Stochastic Oscillator | 95.59 | 62.33 |
LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).